Science Explorer Back to mapMap
Discussion

Gastrointestinal Tumor Research and Treatment

Gastrointestinal Tumor Research and Treatment is a research topic within Gastroenterology. Science Explorer counts 32k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation.

  • Imatinib Mesylate
  • Sunitinib
  • PDGFRA Mutations
  • KIT Mutations
  • GIST Consensus Conference
  • Surgical Management
  • Prognostic Factors
  • EUS-guided Fine Needle Aspiration
  • SDH Deficiency
  • PET Imaging
Research works
32k
fractional, since 1950
In the world top 10%
3.3k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
China
29% of the 10 largest, 2022-now
Gastrointestinal Tumor Research and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Gastrointestinal Tumor Research and Treatment research?

By volume, China and the United States publish the most (1.5k and 1.2k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.5k works
  2. 2 United States 1.2k works
  3. 3 Japan 893 works
  4. 4 India 312 works
  5. 5 South Korea 250 works
  6. 6 Italy 249 works
  7. 7 United Kingdom 193 works
  8. 8 Germany 191 works
  9. 9 Spain 156 works
  10. 10 France 137 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 29.2%United States: 23.6%Japan: 17.7%India: 6.2%6 others listed: 23.3%29%largest
China1,476 · 29.2%United States1,194 · 23.6%Japan893 · 17.7%India312 · 6.2%6 others listed1,175 · 23.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Gastrointestinal Tumor Research and Treatment research?

By volume in 2022-now, Sun Yat-sen University publishes the most Gastrointestinal Tumor Research and Treatment research, followed by Sichuan University and Harvard University.

Who are the leading researchers in Gastrointestinal Tumor Research and Treatment?

The most-cited researchers publishing on Gastrointestinal Tumor Research and Treatment include Guido Kroemer, Gad A. Getz and Jun Wang.

  1. 1 Guido Kroemer France 386k citations
  2. 2 Gad A. Getz United States 364k citations
  3. 3 Jun Wang China 340k citations
  4. 4 Matthew M. Meyerson United States 280k citations
  5. 5 Chris Sander United States 276k citations
  6. 6 Hagop M. Kantarjian United States 273k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Gastrointestinal Tumor Research and Treatment?

The most cited paper in Gastrointestinal Tumor Research and Treatment is "Comprehensive molecular characterization of gastric adenocarcinoma" (Adam Joel Bass et al., 2014), with 6,680 citations. Next come "Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer" (6,432) and "Gastric cancer" (5,024).

Most cited papers
#PaperReleasedCitations
1 Comprehensive molecular characterization of gastric adenocarcinoma Adam Joel Bass et al. · Nature Open access258 authors 23 Jul 2014 6,680
2 Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer David Cunningham, William Allum, Sally Patricia Stenning et al. · New England Journal of Medicine 6 Jul 2006 6,432
3 Gastric cancer Elizabeth Catherine Smyth, Magnus Nilsson, Heike Irmgard Grabsch et al. · The Lancet Aug 2020 5,024
4 Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors Seiichi Hirota, Koji Isozaki, Yasuhiro Moriyama et al. · Science 23 Jan 1998 4,517
5 Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors George D. Demetri et al. · New England Journal of Medicine Open access 15 Aug 2002 4,425
All 100 most cited papers, with filters and sorting

Where is Gastrointestinal Tumor Research and Treatment research done?

The largest centres of Gastrointestinal Tumor Research and Treatment research in 2022-now are Tokyo (Japan), Beijing (China), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa.

Largest cities, 2022-now

  1. 1 TokyoJapan 202 works
  2. 2 BeijingChina 155 works
  3. 3 ShanghaiChina 120 works
  4. 4 SeoulSouth Korea 120 works
  5. 5 GuangzhouChina 99 works
  6. 6 OsakaJapan 76 works
  7. 7 ChengduChina 74 works
  8. 8 HangzhouChina 70 works
  9. 9 NanjingChina 69 works
  10. 10 New YorkUnited States 69 works

Where it is the local speciality

  1. KashiwaJP · 23.7 works41×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Gastrointestinal Tumor Research and Treatment than the world average.

See Gastrointestinal Tumor Research and Treatment on the map

Where is the best place to study Gastrointestinal Tumor Research and Treatment?

Among universities, judged by research, Harvard University, Sun Yat-sen University and Humanitas University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.24%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityHumanitas UniversityFujian Medical Unive…Sun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 69.923.4%2.4×42 -15.2%
2Sun Yat-sen UniversityChina 68.115.0%5.6×65 +26.4%
3Humanitas UniversityItaly 60.818.7%17.7×14 +101.9%
4Fujian Medical UniversityChina 59.915.1%12.4×38 +21.3%
5Fudan UniversityChina 58.313.0%4.2×38 +33.4%
6Peking UniversityChina 57.515.7%3.2×37 +8.6%
7Nanjing Medical UniversityChina 56.612.0%8.3×42 +37.3%
8Sichuan UniversityChina 55.910.3%3.9×50 +18.4%
9Sungkyunkwan UniversitySouth Korea 55.529.7%4.7×18 -19.2%
10Utrecht UniversityNetherlands 54.829.5%2.0×8 -8.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Gastrointestinal Tumor Research and Treatment, country by country

Is Gastrointestinal Tumor Research and Treatment research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Gastrointestinal Tumor Research and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Gastrointestinal Tumor Research and Treatment as a percentage of every work published that year, 0.028% in 2024.

still counting0.020%0.040%Gastrointestinal Tumor Research and Treatment0.026% in 202519801990200020102020

Fractional works of Gastrointestinal Tumor Research and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Gastrointestinal Tumor Research and Treatment10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Gastrointestinal Tumor Research and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.